USFDA okays new antibiotic for highly drug-resistant tuberculosis

Pretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news